Fortress Biotech, Inc.

  • Home
  • About
    • Overview
    • Business Development
    • Management Team
    • Board of Directors
    • FAQ
  • Programs
    • Pipeline
    • Marketed Products
    • Publications
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • Analyst Coverage
    • SEC Filings
    • Governance
    • Resources
  • Contact
  • Careers
  • FAQ
  • Accessibility Statement

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events

Journey Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

May 22, 2023

Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 22, 2023

May 19, 2023

Mustang Bio Announces Strategic Manufacturing Partnership and Portfolio Updates

May 18, 2023

Checkpoint Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

May 15, 2023

Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

May 15, 2023

Mustang Bio Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

May 12, 2023

Avenue Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights

May 12, 2023

Mustang Bio Announces Upcoming Presentations of Clinical Data from Phase 1/2 Trial of MB-106, a CD20-Targeted Autologous CAR T Cell Therapy

May 11, 2023

Journey Medical Corporation Announces Postponement of First Quarter Financial Results Release and Conference Call

May 11, 2023

Journey Medical Corporation to Announce First Quarter 2023 Financial Results on May 11, 2023

May 04, 2023
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10

    Fortress Biotech programs include product candidates in development at Fortress, its majority-owned and majority-controlled partner companies and entities in which it holds minority ownership positions.

    © 2025 Fortress Biotech, Inc. All Rights Reserved.
    Facebook Twitter Linkedin
    Accessibility Statement Privacy Policy Disclaimer Sitemap